Dr. Konkle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
921 Terry Ave
Puget Sound Blood Center
Seattle, WA 98104Phone+1 206-233-3349Fax+1 866-291-0025
Education & Training
University of MichiganFellowship, Hematology and Medical Oncology, 1984 - 1988
Rush University Medical CenterResidency, Internal Medicine, 1979 - 1982
Vanderbilt University School of MedicineClass of 1979
Certifications & Licensure
WA State Medical License 2009 - 2026
PA State Medical License 1988 - 2010
IL State Medical License 1979 - 1984- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Optimal Platelet Dose Strategy for Management of Thrombocytopenia Start of enrollment: 2004 Jul 01
- Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures Start of enrollment: 2006 Mar 01
- Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) Start of enrollment: 2008 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 285 citationsInherited causes of clonal haematopoiesis in 97,691 whole genomes.Alexander G. Bick, Joshua S. Weinstock, Satish K. Nandakumar, Charles P. Fulco, Erik L. Bao
Nature. 2020-10-14 - 63 citationsCrucial role for the VWF A1 domain in binding to type IV collagen.Veronica H. Flood, Abraham C. Schlauderaff, Sandra L. Haberichter, Tricia L. Slobodianuk, Paula M. Jacobi
Blood. 2015-04-02 - 664 citationsMean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysisSarah G. Chu, Richard C. Becker, Peter B. Berger, Deepak L. Bhatt, John W. Eikelboom
Journal of Thrombosis and Haemostasis. 2010-01-01
Abstracts/Posters
- Von Willebrand Disease Minimize Menorrhagia (VWDMin) TrialBarbara A. Konkle, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- Updated Follow-up of the Alta Study, a Phase 1/2, Open Label, Adaptive, Dose-Ranging Study to Assess the Safety and Tolerability of SB-525 Gene Therapy in Adult Patien...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- ASPIRE Final Results Confirm Established Safety and Sustained Efficacy for Up to 4 Years of Treatment With rFVIIIFc in Previously Treated Subjects With Severe Hemophil...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- 2012 American Society of Hematology State-of-the-Art SymposiumAmerican Society of Hematology (ASH), Chicago, Illinois - 9/28/2012
- Join now to see all
Other
- Antithrombotic therapy in patients with prosthetic heart valvesKonkle BA, Aurigemma GP, Gaasch WH
http://www.uptodate.com/contents/antithrombotic-therapy-in-patients-with-prosthetic-heart-valves
UpToDate, Wolters Kluwer Health - 2013-03-29
Press Mentions
Gene Therapy—a Dream Come True?August 6th, 2020
Sangamo and Pfizer Announce Updated Results in Gene Therapy TreatmentDecember 18th, 2019- Sangamo to Present Gene Therapy and Ex Vivo Gene-Edited Cell Therapy DataNovember 7th, 2019
- Join now to see all
Grant Support
- Von Willebrand Factor In Sickle Cell Disease PathophysiologyNational Heart, Lung, And Blood Institute2012
- A Pilot Study Of Lmwh For Post-Partum Prophylaxis In Women At Risk Of Venous ThroNational Heart, Lung, And Blood Institute2011
- A Cross-Sectional Analysis Of Cardiovascular Disease In The Hemophilia PopulationCenters For Disease Control And Prevention2011
- Novel Biomarkers Predictive Of Heparin-Induced ThrombocytopeniaNational Heart, Lung, And Blood Institute2009–2010
- Age Dependent Thrombotic Risk Factors In Heparin-Induced ThrombocytopeniaNational Heart, Lung, And Blood Institute2007–2008
- Mentored Career Development In Clinical Research In Non-Malignant HematologyNational Heart, Lung, And Blood Institute2006–2008
- Prevention Of The Complications Of Bleeding Disorders Through HtcsCenters For Disease Control And Prevention2006–2007
- Transfusion/Hemostasis Clinical Research NetworkNational Heart, Lung, And Blood Institute2002–2007
- Plasminogen Activator Inhibitor 1 Gene ExpressionNational Heart, Lung, And Blood Institute1994
- Plasminogen Activator Inhibitor-1 Gene ExpressionNational Heart, Lung, And Blood Institute1990–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
